Puma Biotechnology (PBYI) Gross Margin Growth (5y) (2022 - 2026)

Puma Biotechnology (PBYI) Gross Margin Growth (5y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Puma Biotechnology 407.27 Mn 368.99 Mn 34.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 685.00
Dec 31, 2025 -984.00
Sep 30, 2025 -276.00
Jun 30, 2025 -1,012.00
Mar 31, 2025 -522.00
Dec 31, 2024 -745.00
Sep 30, 2024 -1,950.00
Jun 30, 2024 -536.00
Mar 31, 2024 -1,645.00
Dec 31, 2023 -1,912.00
Sep 30, 2023 -923.00
Jun 30, 2023 -433.00
Mar 31, 2023 -1,545.00
Dec 31, 2022 -48.00
Sep 30, 2022 323.00